Karyopharm Therapeutics (KPTI) PT Lowered to $14 at Wedbush
Tweet
Share
E-mailGet Alerts KPTI Hot Sheet
Price: $1.85 -10.19%
Rating Summary:
11 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
11 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Wedbush analyst David Nierengarten lowered the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $14.00 (from $19.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ultrapar Participacoes SA (UGPA3:BZ) (UGP) PT Raised to BRL39 at JPMorgan
- Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
